Invention Grant
- Patent Title: Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
-
Application No.: US16569986Application Date: 2019-09-13
-
Publication No.: US10933045B2Publication Date: 2021-03-02
- Inventor: Timothy Matthias Morgan
- Applicant: Lachesis Biosciences Limited
- Applicant Address: AU Warrnambool
- Assignee: Lachesis Biosciences Limited
- Current Assignee: Lachesis Biosciences Limited
- Current Assignee Address: AU Warrnambool
- Agency: Lathrop GPM, LLC
- Agent Brian C. Trinque
- Priority: AU2014903944 20141003
- Main IPC: A61K31/325
- IPC: A61K31/325 ; A61K9/00 ; A61K47/12 ; A61K47/32 ; A61K31/27 ; A61K47/10 ; A61K31/13 ; A61P25/28 ; A61P25/16 ; A61K9/08 ; A61K31/439 ; A61K31/445 ; A61K31/485 ; A61K45/06
Abstract:
The present invention relates generally to intranasal pharmaceutical compositions. In particular, the present invention is directed to sustained, enhanced delivery of pharmaceutical agents across the nasal mucosa for systemic drug delivery.
Public/Granted literature
- US20200078331A1 Intranasal Compositions For Treatment of Neurological And Neurodegenerative Diseases And Disorders Public/Granted day:2020-03-12
Information query
